Insight Molecular Diagnostics Inc. /
Chronix Biomedical, Inc.
Insight Molecular Diagnostics Inc. signed an agreement for Chronix Biomedical, Inc.
Source for the buyer and target: Insight Molecular Diagnostics Inc.
For the buyer and target.
buyer
“As previously reported, Insight Molecular Diagnostics Inc. (the “Company” or “iMDx”) entered into an Agreement and Plan of Merger dated February 2, 2021, amended February 23, 2021, and amended and restated as of April 15, 2021 (as amended and restated, the “Merger Agreement”), by and among the Company, CNI Monitor Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”), Chronix, the stockholders party to the Merger Agreement (the “Stockholders”) and the equity holder representative.”
Published 21 Sep 2026
Open the sourceWhat happened
The deal for Chronix Biomedical, Inc. is signed, with Insight Molecular Diagnostics Inc. as the buyer. [01]
The filing from Insight Molecular Diagnostics Inc. is dated Sept. 21, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Insight Molecular Diagnostics Inc. signed an agreement for Chronix Biomedical, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly